Filing Details
- Accession Number:
- 0001140361-12-027462
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-25 17:53:18
- Reporting Period:
- 2012-05-23
- Filing Date:
- 2012-05-25
- Accepted Time:
- 2012-05-25 16:53:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
350907 | Thoratec Corp | THOR | Electromedical & Electrotherapeutic Apparatus (3845) | 942340464 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1248380 | F Neil Dimick | 6035 Stoneridge Drive Pleasanton CA 94551 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-23 | 5,579 | $0.00 | 39,626 | No | 4 | A | Direct | |
Common Stock | Disposition | 2012-05-25 | 1,273 | $31.47 | 38,353 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents restricted stock units. Each restricted stock unit represents a right to receive one share of Thoratec Corporation common stock upon vesting. The restricted stock units vest in four equal annual installments commencing one year after the grant date.
- Annual stock grant according to the Company's 2006 Incentive Stock Plan.
- Restricted stock units were granted pursuant to the Company's 2006 Incentive Stock Plan with no payment received for the restricted stock units.
- Shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on March 2, 2012, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act 1934, as amended.
- This transaction was executed in multiple trades in prices ranging from $31.32 to $31.68. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.